Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues? (original) (raw)
Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF
E. Kolibianakis, Johan Schiettecatte
Human Reproduction, 2004
View PDFchevron_right
Addition of GnRH antagonist in cycles of poor responders undergoing IVF
Esra Aksoy, Halit Erden
Human Reproduction, 2000
View PDFchevron_right
In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF
Haris E . Cazlaris
Human Reproduction, 2005
View PDFchevron_right
Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT
Raffaella Depalo
International Journal of Reproductive BioMedicine, 2018
View PDFchevron_right
Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study
Deepika Krishna
Journal of reproduction & infertility, 2012
View PDFchevron_right
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles
Anne Zedeler
Human Reproduction, 2016
View PDFchevron_right
GnRH-Agonist Ovulation Trigger in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF with Stop GnRH-Agonist Combined with Multidose GnRH-Antagonist Protocol
Raoul Orvieto
Gynecologic and Obstetric Investigation, 2021
View PDFchevron_right
Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes
Michael Kruger
Journal of Assisted Reproduction and Genetics, 2008
View PDFchevron_right
Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer
Abdelhamid BENMACHICHE
Frontiers in Endocrinology
View PDFchevron_right
Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET
Byron Asimakopoulos
Archives of Gynecology and Obstetrics, 2014
View PDFchevron_right
Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
Raoul Orvieto
Frontiers in Endocrinology, 2020
View PDFchevron_right
GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial
Yannis Panagiotidis
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
View PDFchevron_right
Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome
Walter Vegetti
Human Reproduction, 2005
View PDFchevron_right
Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study
isabelle cedrin
Human Reproduction, 2004
View PDFchevron_right
Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy
Judith Huirne
Human Reproduction, 2004
View PDFchevron_right
GnRH antagonist in IVF poor-responder patients: results of a randomized trial
Massimo Moscarini
Reproductive BioMedicine Online, 2005
View PDFchevron_right
Relationship between LH and oestradiol in IVF cycles before GnRH antagonist initiation
Michel Camus
2003
View PDFchevron_right
Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation
Yves Thorrez
Human Reproduction, 2019
View PDFchevron_right
Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial
Arie Verhoeff
Human Reproduction, 2013
View PDFchevron_right
Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing
Salvatore Gizzo
Molecular Medicine Reports, 2015
View PDFchevron_right
The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates--a randomized, double-blinded, placebo-controlled trial
Donatella Caserta
Human Reproduction, 2011
View PDFchevron_right
Is a premature rise in luteinizing hormone in the absence of increased progesterone levels detrimental to pregnancy outcome in GnRH antagonist in vitro fertilization cycles
Janet Catov, Debbie Jacobson
Fertility and Sterility, 2011
View PDFchevron_right
The value of LH supplementation in young women with diminished ovarian reserve treated with GnRH Antagonist Protocol for ovarian hyperstimulation in ICSI-cycles
Berna Dilbaz
Ginekologia Polska, 2021
View PDFchevron_right
GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial
Francesca Sammartano
Human Reproduction, 2006
View PDFchevron_right
The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments
Johan Schiettecatte
Human Reproduction, 2012
View PDFchevron_right
A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders interv...
S. Sunkara, Peter Braude
Reproductive Health, 2007
View PDFchevron_right
Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study
CLAUDIA PETERSEN
Reprod Biol …, 2009
View PDFchevron_right